NASDAQ:BYSI

Beyondspring Stock Predictions

etoro logo Buy BYSI
*Your capital is at risk
$1.74
+0.0400 (+2.35%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BYSI Prediction Chart

BYSI Predictions History

Latest community submissions for BYSI.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 22, 2025 $2.26 -3.69% $1.90 V 80.88% 1
Dec 22, 2025 $2.30 -2.30% $1.90 V 79.17% 1
Dec 22, 2025 Bullish $1.90 X 0
Mar 4, 2025 $1.72 +2.11% $1.70 V 99.09% 2
Mar 4, 2025 $1.70 +1.32% $1.70 V 99.87% 6
Mar 4, 2025 Bullish $1.70 V 1
JS JS Pro
Jan 10, 2022 $4.57 +7.28% $4.26 X 92.72% 0
Jan 7, 2022 $4.80 +5.96% $4.53 X 94.04% 1
JS JS Pro
Jan 6, 2022 $4.79 +6.44% $4.50 X 93.56% 0
Jan 6, 2022 Bullish $4.50 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BYSI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BEYONDSPRING INC
BeyondSpring
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combinati...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE